We are committed to good business practices, transparency in financial reporting, and vigorous and effective corporate governance. Working together with management and our advisors, our board of directors continues to evaluate CTI's policies and procedures to maintain compliance with laws and regulations and effectively manage the affairs of CTI.

Our directors bring to the Company a wide range of experience, knowledge and judgment. These varied skills mean that good governance depends on more than a "check the box" approach to standards or procedures. Our governance structure is designed to be a working structure for principled actions, effective decision-making and appropriate monitoring of both compliance and performance.

To be effective, our directors maintain an attitude of constructive skepticism and review of CTI's operations. Our directors know that their job requires them to ask probing questions of management and to take action designed to get accurate and honest answers. Our directors also rely on the advice, reports, and opinions of management, counsel and our other expert advisors. In doing so the board of directors constantly evaluates the qualifications of those it relies on for information and advice, and also looks to the process used by managers and advisors in reaching their recommendations.

We believe that effective corporate governance is critical to achieving our mission of making cancer more treatable while providing value for our employees, customers, and stockholders. We are committed to the highest standards of ethics in the conduct of our business.